The osteochondral dilemma: Review of current management and future trends

ANZ Journal of Surgery

Volumn 84, Issue 4, 2014, Pages 211-217

  Ye, Ken ^a,b   Di Bella, Claudia ^a,b   Myers, Damian E ^a,b   Choong, Peter F M ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

Bioengineering; Cartilage; Defects; Regeneration; Review

Indexed keywords

ARTHROSCOPY; ARTICULAR CARTILAGE; BONE TRANSPLANTATION; CARTILAGE CELL; CHONDROPLASTY; DEBRIDEMENT; HUMAN; HYALINE CARTILAGE; KNEE INJURIES; ORTHOPEDIC SURGERY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; TISSUE ENGINEERING; TRANSPLANTATION; TRENDS; WOUND HEALING;

ARTHROPLASTY, SUBCHONDRAL; ARTHROSCOPY; BONE TRANSPLANTATION; CARTILAGE, ARTICULAR; CHONDROCYTES; DEBRIDEMENT; HUMANS; HYALINE CARTILAGE; KNEE INJURIES; ORTHOPEDIC PROCEDURES; TISSUE ENGINEERING; WOUND HEALING;

EID: 84897414329     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/ans.12108     Document Type: Review

References (65)

1. Tuan RS. A second-generation autologous chondrocyte implantation approach to the treatment of focal articular cartilage defects. Arthritis Res. Ther. 2007; 9: 109.
2. Vinatier C, Bouffi C, Merceron C etal. Cartilage tissue engineering: towards a biomaterial-assisted mesenchymal stem cell therapy. Curr. Stem Cell Res. Ther. 2009; 4: 318-329.
3. Kheir ESD. Management of articular cartilage defects. Orthop. Trauma 2009; 23: 266-273.
4. Curl WW, Krome J, Gordon ES, Rushing J, Smith BP, Poehling GG. Cartilage injuries: a review of 31, 516 knee arthroscopies. Arthroscopy 1997; 13: 456-460.
5. Hjelle K, Solheim E, Strand T, Muri R, Brittberg M. Articular cartilage defects in 1, 000 knee arthroscopies. Arthroscopy 2002; 18: 730-734.
6. Widuchowski W, Widuchowski J, Trzaska T. Articular cartilage defects: study of 25, 124 knee arthroscopies. Knee 2007; 14: 177-182.
7. Ulrich-Vinther M, Maloney MD, Schwarz EM, Rosier R, O'Keefe RJ. Articular cartilage biology. J. Am. Acad. Orthop. Surg. 2003; 11: 421-430.
8. Poole AR, Kojima T, Yasuda T, Mwale F, Kobayashi M, Laverty S. Composition and structure of articular cartilage: a template for tissue repair. Clin. Orthop. Relat. Res. 2001; 391 (Suppl): S26-33.
9. Mollenhauer JA. Perspectives on articular cartilage biology and osteoarthritis. Injury 2008; 39 (Suppl. 1): S5-12.
10. Newman AP. Articular cartilage repair. Am. J. Sports Med. 1998; 26: 309-324.
11. Shapiro F, Koide S, Glimcher MJ. Cell origin and differentiation in the repair of full-thickness defects of articular cartilage. J. Bone Joint Surg. Am. 1993; 75: 532-553.
12. Furukawa T, Eyre DR, Koide S, Glimcher MJ. Biochemical studies on repair cartilage resurfacing experimental defects in the rabbit knee. J. Bone Joint Surg. Am. 1980; 62: 79-89.
13. Knutsen G, Engebretsen L, Ludvigsen TC etal. Autologous chondrocyte implantation compared with microfracture in the knee. A randomized trial. J. Bone Joint Surg. Am. 2004; 86-A: 455-464.
14. Knutsen G, Drogset JO, Engebretsen L etal. A randomized trial comparing autologous chondrocyte implantation with microfracture. Findings at five years. J. Bone Joint Surg. Am. 2007; 89: 2105-2112.
15. Gudas R, Kalesinskas RJ, Kimtys V etal. A prospective randomized clinical study of mosaic osteochondral autologous transplantation versus microfracture for the treatment of osteochondral defects in the knee joint in young athletes. Arthroscopy 2005; 21: 1066-1075.
16. Dozin B, Malpeli M, Cancedda R etal. Comparative evaluation of autologous chondrocyte implantation and mosaicplasty: a multicentered randomized clinical trial. Clin. J. Sport Med. 2005; 15: 220-226.
17. Bentley G, Biant LC, Carrington RW etal. A prospective, randomised comparison of autologous chondrocyte implantation versus mosaicplasty for osteochondral defects in the knee. J. Bone Joint Surg. Br. 2003; 85: 223-230.
18. Saris DB, Vanlauwe J, Victor J etal. Characterized chondrocyte implantation results in better structural repair when treating symptomatic cartilage defects of the knee in a randomized controlled trial versus microfracture. Am. J. Sports Med. 2008; 36: 235-246.
19. Clouet J, Vinatier C, Merceron C etal. From osteoarthritis treatments to future regenerative therapies for cartilage. Drug Discov. Today 2009; 14: 913-925.
20. Clair BL, Johnson AR, Howard T. Cartilage repair: current and emerging options in treatment. Foot Ankle Spec. 2009; 2: 179-188.
21. Hubbard MJ. Articular debridement versus washout for degeneration of the medial femoral condyle. A five-year study. J. Bone Joint Surg. Br. 1996; 78: 217-219.
22. Moseley JB, O'Malley K, Petersen NJ etal. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N. Engl. J. Med. 2002; 347: 81-88.
23. Breinan HA, Martin SD, Hsu HP, Spector M. Healing of canine articular cartilage defects treated with microfracture, a type-II collagen matrix, or cultured autologous chondrocytes. J. Orthop. Res. 2000; 18: 781-789.
24. Frisbie DD, Oxford JT, Southwood L etal. Early events in cartilage repair after subchondral bone microfracture. Clin. Orthop. Relat. Res. 2003; 407: 215-227.
25. Bae DK, Yoon KH, Song SJ. Cartilage healing after microfracture in osteoarthritic knees. Arthroscopy 2006; 22: 367-374.
26. Steadman JR, Rodkey WG, Rodrigo JJ. Microfracture: surgical technique and rehabilitation to treat chondral defects. Clin. Orthop. Relat. Res. 2001; 391 (Suppl): S362-369.
27. Steadman JR, Ramappa AJ, Maxwell RB, Briggs KK. An arthroscopic treatment regimen for osteoarthritis of the knee. Arthroscopy 2007; 23: 948-955.
28. Steadman JR, Briggs KK, Rodrigo JJ, Kocher MS, Gill TJ, Rodkey WG. Outcomes of microfracture for traumatic chondral defects of the knee: average 11-year follow-up. Arthroscopy 2003; 19: 477-484.
29. Gobbi A, Nunag P, Malinowski K. Treatment of full thickness chondral lesions of the knee with microfracture in a group of athletes. Knee Surg. Sports Traumatol. Arthrosc. 2005; 13: 213-221.
30. Mithoefer K, Williams RJ 3rd, Warren RF etal. The microfracture technique for the treatment of articular cartilage lesions in the knee. A prospective cohort study. J. Bone Joint Surg. Am. 2005; 87: 1911-1920.
31. Mithoefer K, Williams RJ 3rd, Warren RF, Wickiewicz TL, Marx RG. High-impact athletics after knee articular cartilage repair: a prospective evaluation of the microfracture technique. Am. J. Sports Med. 2006; 34: 1413-1418.
32. Kreuz PC, Erggelet C, Steinwachs MR etal. Is microfracture of chondral defects in the knee associated with different results in patients aged 40 years or younger? Arthroscopy 2006; 22: 1180-1186.
33. Hangody L, Kish G, Karpati Z, Szerb I, Udvarhelyi I. Arthroscopic autogenous osteochondral mosaicplasty for the treatment of femoral condylar articular defects. A preliminary report. Knee Surg. Sports Traumatol. Arthrosc. 1997; 5: 262-267.
34. Bedi A, Feeley BT, Williams RJ 3rd. Management of articular cartilage defects of the knee. J. Bone Joint Surg. Am. 2010; 92: 994-1009.
35. Lane JG, Massie JB, Ball ST etal. Follow-up of osteochondral plug transfers in a goat model: a 6-month study. Am. J. Sports Med. 2004; 32: 1440-1450.
36. Kish G, Modis L, Hangody L. Osteochondral mosaicplasty for the treatment of focal chondral and osteochondral lesions of the knee and talus in the athlete. Rationale, indications, techniques, and results. Clin. Sports Med. 1999; 18: 45-66.
37. Hangody L, Fules P. Autologous osteochondral mosaicplasty for the treatment of full-thickness defects of weight-bearing joints: ten years of experimental and clinical experience. J. Bone Joint Surg. Am. 2003; 85-A (Suppl. 2):25-32.
38. Ozturk A, Ozdemir MR, Ozkan Y. Osteochondral autografting (mosaicplasty) in grade IV cartilage defects in the knee joint: 2- to 7-year results. Int. Orthop. 2006; 30: 200-204.
39. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N. Engl. J. Med. 1994; 331: 889-895.
40. Gooding CR, Bartlett W, Bentley G, Skinner JA, Carrington R, Flanagan A. A prospective, randomised study comparing two techniques of autologous chondrocyte implantation for osteochondral defects in the knee: periosteum covered versus type I/III collagen covered. Knee 2006; 13: 203-210.
41. Zaslav K, Cole B, Brewster R etal. A prospective study of autologous chondrocyte implantation in patients with failed prior treatment for articular cartilage defect of the knee: results of the Study of the Treatment of Articular Repair (STAR) clinical trial. Am. J. Sports Med. 2009; 37: 42-55.
42. Gillogly SD, Voight M, Blackburn T. Treatment of articular cartilage defects of the knee with autologous chondrocyte implantation. J. Orthop. Sports Phys. Ther. 1998; 28: 241-251.
43. Peterson L, Brittberg M, Kiviranta I, Akerlund EL, Lindahl A. Autologous chondrocyte transplantation. Biomechanics and long-term durability. Am. J. Sports Med. 2002; 30: 2-12.
44. Zheng MH, Willers C, Kirilak L etal. Matrix-induced autologous chondrocyte implantation (MACI): biological and histological assessment. Tissue Eng. 2007; 13: 737-746.
45. Behrens P, Bitter T, Kurz B, Russlies M. Matrix-associated autologous chondrocyte transplantation/implantation (MACT/MACI) - 5-year follow-up. Knee 2006; 13: 194-202.
46. Bartlett W, Skinner JA, Gooding CR etal. Autologous chondrocyte implantation versus matrix-induced autologous chondrocyte implantation for osteochondral defects of the knee: a prospective, randomised study. J. Bone Joint Surg. Br. 2005; 87: 640-645.
47. Vanlauwe J, Saris DB, Victor J, Almqvist KF, Bellemans J, Luyten FP. Five-year outcome of characterized chondrocyte implantation versus microfracture for symptomatic cartilage defects of the knee: early treatment matters. Am. J. Sports Med. 2011; 39: 2566-2574.
48. Gudas R, Gudaite A, Pocius A etal. Ten-year follow-up of a prospective, randomized clinical study of mosaic osteochondral autologous transplantation versus microfracture for the treatment of osteochondral defects in the knee joint of athletes. Am. J. Sports Med. 2012; 40: 2499-2508.
49. Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Trials 2010; 11: 32.
50. Martin I, Miot S, Barbero A, Jakob M, Wendt D. Osteochondral tissue engineering. J. Biomech. 2007; 40: 750-765.
51. Biomet I. Biomet announces aquisition of the assets of cartilage repair company Cartilix. Edition. Warsaw, Indiana. [Cited 5 Sep 2012.] Available from URL: http://www.biomet.com/cartilix/index.cfm
52. Hoemann CD, Sun J, McKee MD etal. Chitosan-glycerol phosphate/blood implants elicit hyaline cartilage repair integrated with porous subchondral bone in microdrilled rabbit defects. Osteoarthritis Cartilage 2007; 15: 78-89.
53. Regentis. GelrinC - Synchronized with Nature. Edition. Haifa, Israel. [Cited 5 Sep 2012.] Available from URL: http://www.regentis.co.il/product.asp?ID=1
54. Lange J, Follak N, Nowotny T, Merk H. [Results of SaluCartilage implantation for stage IV chondral defects in the knee joint area]. Unfallchirurg 2006; 109: 193-199.
55. Meyer C, Horas U, Horbelt R, Schnettler R. [Dislocation of artificial cartilage (SaluCartialge)]. Unfallchirurg 2005; 108: 163-166.
56. TiGenix. TiGenix announces the grant of a US patent for ChondroMimetic. Leuven, Belgium, 2010.
57. Melton JT, Wilson AJ, Chapman-Sheath P, Cossey AJ. TruFit CB bone plug: chondral repair, scaffold design, surgical technique and early experiences. Expert Rev. Med. Devices 2010; 7: 333-341.
58. Carmont MR, Carey-Smith R, Saithna A, Dhillon M, Thompson P, Spalding T. Delayed incorporation of a TruFit plug: perseverance is recommended. Arthroscopy 2009; 25: 810-814.
59. Williams RJ, Gamradt SC. Articular cartilage repair using a resorbable matrix scaffold. Instr. Course Lect. 2008; 57: 563-571.
60. De Bie C. Genzyme: 15 years of cell and gene therapy research. Regen. Med. 2007; 2: 95-97.
61. Haddo O, Mahroof S, Higgs D etal. The use of chondrogide membrane in autologous chondrocyte implantation. Knee 2004; 11: 51-55.
62. Nehrer S, Dorotka R, Domayer S, Stelzeneder D, Kotz R. Treatment of full-thickness chondral defects with hyalograft C in the knee: a prospective clinical case series with 2 to 7 years' follow-up. Am. J. Sports Med. 2009; 37 (Suppl. 1):81S-87.
63. Crawford DC, DeBerardino TM, Williams RJ 3rd. NeoCart, an autologous cartilage tissue implant, compared with microfracture for treatment of distal femoral cartilage lesions: an FDA phase-II prospective, randomized clinical trial after two years. J. Bone Joint Surg. Am. 2012; 94: 979-989.
64. Farr J, Cole BJ, Sherman S, Karas V. Particulated articular cartilage: CAIS and DeNovo NT. J. Knee Surg. 2012; 25: 23-29.
65. Hatic SO 2nd, Berlet GC. Particulated juvenile articular cartilage graft (DeNovo NT Graft) for treatment of osteochondral lesions of the talus. Foot Ankle Spec. 2010; 3: 361-364.